EGFR and hearing loss disorder: Search through the literature has yielded only 1 report of EGFR-TKI-induced hearing impairment, wherein a 66-year-old patient developed tinnitus, dizziness, and profound bilateral hearing loss within 0.5 hour after administration of 150 mg of oral erlotinib, leading to irrevocable ototoxicity.